Fig. 1From: Cell membrane-based nanomaterials for theranostics of central nervous system diseases(A) The preparation of T807/RPCNP-CUR by using RBC membrane. (B) TEM image of T807/RPCNP-CUR. (C) in vivo brain-targeting ability of T807/RPCNP-CUR in AD model mice determined by an IVIS® Spectrum. (D) The preparation of RVG/TPP-RSV NPs@RBCm. (E) The preparation of RVG/TPP-MASLNs-GS. Reproduced with permission from Gao et al. [35], Han et al. [70], Han et al. [73]Back to article page